Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
Leukemias driven by chromosomal translocation of the mixed-lineage leukemia gene (MLL or KMT2A) are highly prevalent in pediatric oncology. The poor survival rate and lack of an effective targeted therapy for patients with MLL-rearranged (MLL-r) leukemias emphasize an urgent need for improved knowle...
Main Authors: | Anthony K. N. Chan, Chun-Wei Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2019.00081/full |
Similar Items
-
Research progress in Menin-MLL interaction and its inhibitors in MLL-rearranged leukemia
by: FANG Xinyue, et al.
Published: (2024-10-01) -
SETD2 in MLL-rearranged leukemia – a complex case
by: Anna Skucha, et al.
Published: (2018-07-01) -
Congenital B-lymphoblastic leukemia with a cryptic MLL rearrangement and post-treatment evolution to mixed phenotype acute leukemia
by: Elizabeth Moschiano, et al.
Published: (2016-01-01) -
RNA binding proteins in MLL-rearranged leukemia
by: Tiffany M. Tran, et al.
Published: (2022-10-01) -
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
by: Zizhen Feng, et al.
Published: (2016-03-01)